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C-strain vaccination against Classical Swine Fever 
Management samenvatting  
 
Epidemiologisch deel  
Jantien A. Backer, Willie L.A. Loeffen, H.J.W. van Roermund  
Centraal Veterinair Instituut (CVI), Lelystad 
 
Op het moment komt Klassieke Varkenspest (KVP) niet voor in Nederland en er wordt 
ook niet preventief gevaccineerd tegen de ziekte. Een insleep van het KVP virus vormt 
echter een voortdurende bedreiging voor de Nederlandse varkensstapel. In het huidige 
beleidsdraaiboek is opgenomen dat bij een uitbraak van KVP bij voorkeur noodvaccinatie 
in 2 km ringen rondom een gedetecteerd bedrijf ingezet zal worden als 
beheersmaatregel. Hierbij is gekozen voor een markervaccin (E2-subunit vaccin) 
waardoor onderscheid gemaakt kan worden tussen gevaccineerde en geïnfecteerde 
dieren met de bijbehorende Erns ELISA test. 
 
Nadelen van deze aanpak zijn dat (a) het E2-subunit vaccin een langzame 
immuunrespons opwekt (gevaccineerd bedrijf beschermd in ongeveer 10 dagen), (b) de 
Erns ELISA een lage sensitiviteit heeft en (c) er geen goede confirmatietest beschikbaar is. 
Als alternatief vaccin zou het conventionele C-stam vaccin gebruikt kunnen worden. Dit 
vaccin induceert een zeer snelle immuunrespons in gevaccineerde dieren (gevaccineerd 
bedrijf beschermd in ongeveer 3 dagen), maar mist de markereigenschappen. In de 
eindscreening zullen geïnfecteerde dieren dus niet meer serologisch gedetecteerd kunnen 
worden. Wel kan met PCR vastgesteld worden of dieren al dan niet viruspositief zijn. 
 
In het epidemiologisch deel binnen dit onderzoek worden de verschillen tussen 
noodvaccinatie met het C-stam vaccin of het E2-subunit vaccin geëvalueerd in de 
effectiviteit van bestrijding en de eindscreening. Met behulp van een KVP 
transmissiemodel zijn hypothetische epidemieën gesimuleerd, onder verschillende 
scenario’s. De bestudeerde bestrijdingsstrategieën zijn: EU maatregelen (minimaal 
vereist: ruimen van gedetecteerde bedrijven, instellen van beschermings- en 
toezichtsgebieden, transportmaatregelen en het traceren en screenen van contacten), 
preventief ruimen in 1 km rond gedetecteerde bedrijven en noodvaccinatie met het E2-
subunit vaccin of het C-stam vaccin in 1 km, 2 km of 3 km ringen. Berekend zijn de 
grootte en de duur van de gesimuleerde epidemieën, als maat voor de effectiviteit van de 
beheersmaatregelen. Om inzicht te krijgen in de gevolgen voor de eindscreening is op de 
gesimuleerde epidemieën een eindscreening(model) toegepast. 
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De resultaten van deze studie tonen aan dat voor KVP epidemieën die starten in een 
gebied met hoge veedichtheid zoals De Peel, de minimale maatregelen die door de EU 
worden voorgeschreven niet voldoende zijn om de epidemie te beheersen (Tab. 6). Als 
aanvullende maatregel, verminderen zowel preventieve ruiming als ringvaccinatie de 
duur en de omvang van de epidemie. Preventieve ruiming in 1 km verkort de duur van 
de epidemie het meest, maar dit gaat ten koste van het grootste aantal geruimde 
bedrijven (Tab. 6). Een vergelijkbare effectiviteit door middel van noodvaccinatie wordt 
alleen bereikt bij vaccinatie in 3 km. Daarbij is het C-stam vaccin slechts enigszins 
effectiever dan het E2-subunit vaccin. 
 
Vaccinatie voorkomt infectie niet meteen na toedienen van het vaccin, maar kan de 
virusverspreiding wel vertragen en daarna stoppen door de toenemende bescherming. 
Door het lage aantal besmette dieren op het bedrijf kunnen sommige geïnfecteerde 
bedrijven ongedetecteerd blijven als noodvaccinatie gebruikt wordt ter bestrijding van 
KVP. De aantallen niet-gedetecteerde dieren na de eindscreening in het land zijn 
vergelijkbaar voor E2-subunit en C-stam vaccinatie (Tab. 8) 
 
Tijdens de eindscreening kunnen ook vals positieve uitslagen gevonden worden. Dit zijn 
bedrijven die niet geïnfecteerd zijn (geweest) maar waar wel dieren gevonden worden die 
positief testen in de eerste eindscreening. Voor de non-vaccinatie strategieën (EU 
maatregelen en preventieve ruiming) zijn die aantallen verwaarloosbaar. Voor de C-stam 
vaccinatiestrategieën worden ook geen vals positieven verwacht. E2-subunit vaccinatie 
zal echter enige tientallen vals positieve bedrijven opleveren. De reden zijn de grote 
aantallen te bemonsteren dieren en de relatief lage specificiteit van de Erns ELISA (Tab. 
9). Deze bedrijven zullen nogmaals bezocht moeten worden om de tonsillen van de 
positieve dieren in de PCR te testen (die vervolgens negatief zal zijn). 
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Economisch deel 
Ron Bergevoet, Marcel van Asseldonk 
Landbouw Economisch Instituut LEI, Wageningen 
 
In het economisch deel van het onderzoek zijn de verschillen in economische effecten 
van noodvaccinatie bij een uitbraak van Klassieke Varkenspest (KVP) in een 
veedichtgebied in Nederland onderzocht. Hierbij is een levend vaccin gebaseerd op de C-
stam vergeleken met het vaccin dat op het moment als voorkeursvaccin genoemd wordt 
in de bestrijdingsdraaiboeken (het E2-subunit vaccin).  
De resultaten laten zien dat bij toepassing van een “vaccination-to-live” strategie1 : 
Bij een vaccinatiecirkel van 2 km rond geïnfecteerde bedrijven is de schade lager dan bij 
vaccinatie in een cirkel van 1 km of 3 km voor zowel C-stam als E2-subunit vaccin 
• Er zijn geringe verschillen tussen de vaccinatiestrategie met C-stam of met E2-
subunit vaccin. Dit geringe verschil in het voordeel van C stam geldt alleen als er 
aan een belangrijke voorwaarden rond de afzet van producten van gevaccineerde 
producten is voldaan. Deze rand voorwaarden zijn: 
o Aanvullende hittebehandeling van producten is niet vereist (de huidige 
regelgeving maakt op het ogenblik deze hittebehandeling wel 
noodzakelijk); 
o Er hoeft tijdens de eindscreening van de gevaccineerde dieren maar 1 dier 
per hok van 10 dieren onderzocht te worden met de relatief dure PCR 
techniek; 
o Afnemers in het buitenland accepteren (producten van) niet gevaccineerde 
dieren uit een land waar met C-stam gevaccineerd wordt. 
Op het ogenblik is het onzeker of de beperkte economische voordelen opwegen tegen de 
vele onzekerheden en beperkingen die met de introductie van het C-stam vaccin gepaard 
gaan. 
 
In tabel S1 zijn de belangrijkste resultaten van de berekeningen samengevat. 
Bij de berekeningen zijn alleen de kosten die mogelijk verschillen tussen de onderzochte 
strategieën meegenomen. In deze berekeningen zijn de handhavingskosten en de 
gederfde export inkomsten niet meegenomen.  
 
  
                                                 
1 De gevaccineerde dieren worden pas geslacht op het einde van hun normale productiecyclus en hun producten worden 
gekanaliseerd binnen Nederland afgezet. 
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Tabel S1 Kosten van de verschillende controle strategieën in het geval van een uitbraak 
van KVP in een varkensdicht gebied in Nederland (in Miljoen € per uitbraak) 
 Controle kosten Kosten veehouders Totaal 
  Percentiel  Percentiel  Percentiel 
 Mediaan 0,05 0,95 Mediaan 0,05 0,95 Mediaan 0,05 0,95 
vacE2_1km 35,63 12,13 74,10 12,77 2,57 29,80 48,40 15,40 103,82 
vacE2_2km 27,59 11,18 50,33 17,64 4,93 35,36 45,23 16,56 84,85 
vacE2_3km 25,02 11,05 44,68 23,12 7,65 44,60 48,15 19,66 87,85 
vacC_1km* 32,40 11,91 62,05 10,99 2,63 25,16 43,40 14,70 85,90 
vacC_2km* 26,75 11,43 48,32 15,93 4,44 31,03 42,68 16,73 77,96 
vacC_3km* 25,21 11,14 42,20 21,03 6,90 39,14 46,24 19,31 80,07 
vacC_1kmcul* 75,97 21,73 158,68 9,84 1,65 26,88 85,81 23,76 184,88 
vacC_2kmcul* 108,15 34,20 204,48 11,80 2,32 28,51 119,95 36,76 231,53 
vacC_3kmcul* 140,58 50,76 256,40 14,20 3,19 32,71 154,78 53,64 287,59 
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Summary 
 
The Netherlands is currently free of Classical Swine Fever (CSF) without the use of 
preventive vaccination. However, an introduction of the CSF virus poses a continuous 
threat to the naive pig population. The Dutch contingency plan states that in the case of 
a CSF outbreak, emergency vaccination in 2 km rings around detected farms is preferred 
as additional control measure. Using a marker vaccine (E2-subunit vaccine), vaccinated 
animals can be distinguished from infected animals using the associated Erns ELISA test. 
 
Concerns regarding this approach are that (a) the E2-subunit vaccine induces a slower 
immune response in the animal than conventional vaccines, (b) the Erns ELISA for 
vaccinated animals has a lower sensitivity than the E2 ELISA’s for unvaccinated animals 
and (c) no proper confirmation test is available for E2-subunit vaccinated animals. As an 
alternative, the conventional C-strain vaccine has been proposed, that induces a faster 
immune response in the animal but lacks the marker properties. During the final 
screening, infected C-strain vaccinated animals cannot be detected serologically. Instead, 
they are tested for virus positivity using PCR. 
 
In this project it is evaluated how the use of C-strain vaccine instead of E2-subunit 
vaccine will affect the effectiveness of controlling the epidemic. To this end a CSF 
transmission model was developed that describes virus transmission on three different 
levels: between animals, between pens and between herds. The results of transmission 
and vaccination experiments as well as the data from the 1997/1998 CSF epidemic in 
The Netherlands serve to parameterize the model. With the model hypothetical epidemics 
are simulated under different scenarios. The studied control strategies include EU 
measures (depopulation of detected herds, defining protection and surveillance zones, 
transport regulations, and tracing and screening of dangerous contacts), preemptive 
culling in 1 km around detected herds, and emergency vaccination with the E2-subunit or 
C-strain vaccine in 1 km, 2 km or 3 km rings. The size and duration of the simulated 
epidemics are a measure for the effectiveness of the control strategies. On the simulated 
epidemics a final screening (model) is applied, to assess how many herds and animals 
need to be tested, how many truly positive herds and animals will be detected during the 
final screeing and how many false positive results can be expected. 
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The results of this study show that for CSF epidemics starting in a densely populated 
livestock area such as De Peel, the minimal measures required by the EU are not 
sufficient to control the epidemic (Tab. 6). As additional measure, both preemptive 
culling and ring vaccination decrease the duration and size of the epidemic. Preemptive 
culling shortens the epidemic the most with the smallest control radius of 1 km, at the 
expense of the largest number of depopulated farms (Tab. 6). Similar effectiveness is 
only achieved by emergency vaccination when the control radius is 3 km. In this respect, 
C-strain vaccination is only slightly more effective than E2-subunit vaccination. 
Apparently the time scale of the immune response (3 or 10 days) is sufficiently small 
compared to the virus transmission within a herd (4 to 5 weeks) and between herds to 
effectively control the epidemic. 
 
Vaccination does not prevent infection right after administering the vaccine, but it can 
slow down and eventually halt virus transmission in an infected herd due to the 
increasing protection. Because of the small number of infected animals, some infected 
herds may escape detection when vaccination is used to control CSF. E2-subunit 
vaccination is expected to yield larger numbers (medians of 26 - 38) of not-detected 
infected animals in the country after the epidemic than C-strain vaccination (medians of 
19 - 28) (Tab. 8). During the final screening, infected E2-subunit vaccinated animals can 
be detected via the Erns ELISA. Even though the test sensitivity is not very high, the 
sample sizes (1 animal per pen, or 10% of all animals) are sufficiently large to detect 
even a low seroprevalence. However, the subsequent confirmation test by PCR has a 
sensitivity that decreases over time: 80 days after infection only half of the animals will 
be PCR positive. For this reason, it is not uncommon that an infected herd is detected by 
Erns ELISA, but then declared free of disease when the PCR turns out to be negative. The 
model results show that only 0, 1 or 2 infected herds are detected during the final 
screening. When C-strain vaccination is applied, another screening protocol is followed. 
Serological tests are not applicable, as they will always be positive for C-strain vaccinated 
animals. Instead, blood samples (of 1 animal per pen, or 10% of all animals) are tested 
by PCR. However, as virus will be present in the blood of C-strain vaccinated animals for 
a very short period after infection, none of them will be detected by PCR during the final 
screening. This is why after the final screening, the numbers of not-detected infected 
animals in the country are comparable for E2-subunit and C-strain vaccination (Tab. 8). 
 
During the final screening test results can also be false positive. For the non-vaccination 
strategies (EU measures and preemptive culling) these numbers are negligible, because 
of the relatively small sample sizes from unvaccinated herds and the high test specificity 
of the (series of) serological tests. Also for the C-strain vaccination strategies, no false 
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positive results are expected using PCR testing. E2-subunit vaccination on the other hand 
will yield several dozens of false positive herds, because of the large sample sizes from 
vaccinated herds and the relatively low test specificity of the Erns ELISA (Tab. 9). These 
herds will be visited again to collect the tonsils of the positively testes animals for PCR 
testing (which will yield negative results). 
 
C-strain vaccination is less effective than was expected from the experimental results at 
individual level. The fast immune response induced by the C-strain vaccine will prevent 
most herds to be infected after vaccination. But when an already infected herd is 
vaccinated, the same fast immune response will soon halt the virus transmission and 
prevent detection. This is why C-strain vaccination will also yield undetected infected 
herds. The undetected infected animals in these herds cannot be detected during the 
final screening, as they cannot be distinguished from vaccinated animals. 
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1. Introduction 
 
Classical Swine Fever (CSF) represents a continuous threat to pig populations that are 
free of disease without vaccination. When CSF virus is introduced, the minimal control 
strategy imposed by the EU is often insufficient to mitigate the epidemic. Preemptive 
culling as an additional control measure encounters ethical objections and has been 
abandoned in the updated Dutch contingency plan (Contingency plan Classical Swine 
Fever, 2007). Currently, the preferred additional measure is emergency vaccination using 
the E2-subunit vaccine in 2 km rings. Animals vaccinated with this marker vaccine can be 
distinguished from infected animals using the associated Erns ELISA. The main concerns 
regarding this approach are that (a) the E2-subunit vaccine induces a slower immune 
response in the animal than conventional vaccines, (b) the Erns ELISA for vaccinated 
animals has a lower sensitivity than the E2 ELISA’s for unvaccinated animals and (c) no 
proper confirmation test is available for E2-subunit vaccinated animals. For these 
reasons, it has been proposed to use the conventional C-strain vaccine, that induces a 
fast immune response in the animal (Dewulf et al., 2004). Without the marker 
properties, infected C-strain vaccinated animals cannot be detected serologically, as is 
required for regaining the freedom of disease status (Council Directive 2001/89/EC). 
Instead, they are to be tested by PCR that can detect CSF virus fragments. Arguing that 
PCR negative animals will not pose a problem for re-emergence of the virus (even if they 
would have been infected), it might be accepted as a valid strategy to regain the freedom 
of disease status. 
 
To determine whether C-strain vaccination is a valid alternative to E2-subunit 
vaccination, it must first be evaluated how the use of C-strain vaccine instead of E2-
subunit vaccine will affect the effectiveness of control measures and the results of the 
final screening. Here we will answer these questions using a CSF transmission model to 
assess the effectiveness of several vaccination strategies, and a final screening model to 
assess the effect on the number of not-detected infected herds and animals. 
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2. Methods 
 
2.a CSF transmission model 
 
A stochastic individual-based model was previously developed describing virus 
transmission between animals, pens and farms (Bergevoet et al., 2007, Backer et al., 
2009). Here the within-herd model is further adapted to include three pig types 
(finishers, piglets, sows; Tab. 1). The detection model is improved by imposing a 
detection limit on the number of infectious animals, that reproduces the detection times 
that were observed in the 1997/1998 CSF epidemic in the Netherlands (rather than 
drawing a random detection time). The between-herd model is altered to accommodate 
herds of varying population sizes and mixed farms containing more than one pig type. 
 
The effect of the E2-subunit vaccine on the transmission of CSFV was modelled by 
separate effects on the susceptibility, infectiousness and infectious period of a vaccinated 
animal. For the C-strain vaccine however, infectiousness and infectious period were 
unaffected in vaccinated animals (based on limited experimental data), so only the effect 
on the susceptibility of vaccinated animals is modelled (Tab. 2 and Appendix A). 
 
Table 1 Transmission parameters between animals and pens, for different herd types 
parameter finishing pigs piglets sows 
latent period, Tlat 4 days 4 days 4 days 
infectious period, Tinf,0 15 days (7 – 25)* 15 days (7 – 25) 15 days (7 – 25) 
reproduction number, R0 15.5 100 2.8 
transmission rate 
parameter, β0 
1.03 day-1 6.67 day-1 0.187 day-1 
number of animals per pen, 
Npen 
10 10 1 
total number of animals, N variable variable variable 
within-herd reproduction 
number, R 
2.8 2.8 2.8 
reduction factor between 
pens, ε 
0.018 2.8 ·10-3 1 
detection limit (# infectious 
animals) 
12 23 26 
* Between brackets the (5% - 95%) interval 
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Table 2 Effect of vaccination on CSFV transmission, as function of period τ between 
vaccination and infection (see Appendix A for figures). 
effect of: 
on: 
E2-subunit vaccine C-strain vaccine 
susceptibility Min[1, exp(-0.2(τ-6.4))] Min[1,exp(-0.86 τ)]  
infectiousness (day-1) β0 Min[1,exp(-0.5(τ-6.4))] β0 
average infectious period 
(days) 
Tinf,0 Min[1,(0.21(τ-6.4)+1)-1] Tinf,0 
 
The transmission between herds was modelled as a function k(r) of the distance r 
between source and destination herd: k(r) = k0 / (1+(r/r0)α) (Fig. 1). The transmission 
kernel parameters were estimated as r0 = 1.0 km, α = 2.2, and k0 = 0.0011 day-1 from 
the 1997/1998 CSF epidemic in the Netherlands (Boender et al., 2008, Backer et al., 
2009). 
 
 
Figure 1 Transmission kernel describing the infection probability that a source herd will 
infect a susceptible herd as function of the interfarm distance. 
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2.b Final screening model 
 
All farms in the protection zones of 3 km around detected herds, need to be tested 
during the final screening. Sample sizes are taken based on the type of herd and 
vaccination status. The final screening model calculates how many infected not-detected 
herds and animals can be expected after the final screening, how many cases (truly 
positive herds) are expected to be found during the final screening (setting back the 
freedom of disease status by at least 30 days) and how many herds are expected to be 
declared initially false positive in the final screening. 
 
 
 
 
Figure 2 Schematic overview of final screening model (PZ = protection zone).  
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The final screening is modelled to take place after the simulated epidemic has ended (Fig. 
2). All not-detected infected animals are assumed to have developed a serological 
response, and to be non-viraemic. Unvaccinated animals in the protection zone (3 km 
around IP’s) will be sampled according to EU regulations and tested by E2 ELISA. 
Vaccinated animals will be more intensely screened and tested with either an Erns ELISA 
(for E2-subunit vaccinated animals) or PCR (for C-strain vaccinated animals and as 
confirmation test for E2-subunit vaccinated animals). The test characteristics and 
sampling strategy vary for the different tests (Tab. 3 and Appendix B). 
 
Table 3 Different tests, test characteristics at animal level and sampling strategies to be 
used in the final screening. 
test characteristics applied to sample size 
 sens spec   
E2 serology 92% 99.999% 
unvaccinated finishers 
unvaccinated piglets 
unvaccinated sows 
nsample(0.10,0.95) 
nsample(0.10,0.95) 
nsample(0.05,0.95) 
Erns serology 73.4% 99.9% 
E2-subunit vacc finishers 
E2-subunit vacc piglets 
1 per pen 
1 per pen 
confirmation 
PCR 
sePCR(τ)* 100% 
E2-subunit vacc finishers 
E2-subunit vacc piglets 
1 per pen 
1 per pen 
PCR 0%** 100% 
C-strain vacc finishers 
C-strain vacc piglets 
1 per pen 
1 per pen 
* PCR sensitivity in E2-subunit vaccinated animals decreases with time τ since infection. 
** C-strain vaccinated animals are PCR negative (for the wild virus) soon after infection. 
At final screening none of them will be detected. 
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where q is the design prevalence, seherd the desired herd sensitivity, N the herd size and 
se the test sensitivity. For instance, from an unvaccinated finishing herd of 1000 animals, 
31 are randomly selected to be tested. 
 
First, the final screening model calculates the probability p+neg of missing an infected 
herd, depending on whether a random sample (for E2 serology) or one animal per pen 
(for Erns serology) is tested (Tab. 4). 
 
Table 4 Calculation of final screening results per herd based on the probability p+neg of 
declaring an infected herd false negative, for different test regimes: the number 
Safter of infected not-detected animals after final screening, the probability pcase of 
finding a truly positive herd during the final screening and the probability p-pos of 
finding one false positive animal in a truly negative herd. 
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S p+neg + 
(S–S/m) 
(1–p+neg) 
(1–sePCR(τ)) 
(1–p+neg) 
sePCR(τ) 
1-spn 
PCR 
 
1 
 
0 0 0 
with sample size n, herd size N, pen size m, total number of infected animals S in the 
herd, and their distribution s over the pens (i.e. Σs=S), test sensitivity se, test specificity 
sp, and PCR sensitivity sePCR(τ) depending on time τ since infection. 
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The expected number Safter of not-detected infected animals in the herd after the final 
screening, is found by multiplying p+neg by the number of infected animals S before final 
screening. When a truly positive herd is found, with probability 1–p+neg, teams will return 
to the herd for additional sampling and testing. When in unvaccinated herds (using E2 
serology) evidence of clustering of positive animals or spread is found, the herd will be 
declared a case. In the model this will happen when the total number of infected animals 
S is larger than one. It should be kept in mind that not-vaccinated not-detected infected 
herds outside the protection zone of 3 km, will not be tested and thus not detected 
during the final screening.  
 
In E2-subunit vaccinated herds that were found positive in the Erns ELISA, the additional 
sampling is done by euthanizing the positively tested animals and testing their tonsils in 
PCR. Only when virus fragments are detected, the herd will be declared a case. However, 
the chance of finding a positive PCR result decreases with time since infection (Appendix 
B). This is modelled by a time-dependent PCR sensitivity at animal level sePCR(τ) = 
1/(1+exp(0.088 τ – 7.4)), depending on time τ since infection. For simplicity we assume 
that only one animal (infected half way between the infection and clearance time of the 
herd) is positive when the Erns ELISA is positive. When PCR results are negative, the 
infected animals in the sample (on average S/m) will have been euthanized for the PCR 
testing, but the remainder (on average S–S/m) will be left in the herd, which will add to 
the number Safter of not-detected infected animals after the final screening. Also, the 
probability of not-detecting the infected herd p+neg is increased with (1–p+neg) (1–
sePCR(τ)), i.e. the probability that the herd was  positive in Erns ELISA but negative in PCR. 
 
The probability p-pos of testing a not-infected herd (falsely) positive depends on the test 
specificity and the number of sampled animals. All positive test results will be followed by 
additional sampling and testing, assumed to lead to a 100% specificity. This means that 
p-pos indicates the probability to initially test a herd false positive (and later to be found 
negative). 
 
Summing Safter and p+neg (+(1–p+neg) (1–sePCR(τ)) for E2-subunit vaccinated herds) over 
all infected herds gives the expected total number of not-detected infected animals and 
herds in the country after the final screening and summing pcase over all infected herds 
gives the expected number of truly positive herds found during the final screening. The 
expected total number of herds that are initially tested false positive is the summation of 
p-pos over all not-infected herds in the protection zones (3 km around IP’s). 
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2.c Commercial pig farm data 2011 
 
Dienst Regelingen (Ministry of Economic Affairs) provided pig transport data containing 
the number of pigs that were dispatched from each farm in 2011, in several pig 
categories. From these transport data, the average number of finishers, piglets and sows 
were calculated (Appendix C). Discarding the herds with less than 100 finishers, 100 
piglets or 50 sows, the pig farm database contains 7018 farms (Tab. 5), distributed over 
The Netherlands (Fig. 3). 
 
Table 5 Pig farm data for The Netherlands in year 2011 (calculated from animal transport 
data, Dienst Regelingen) 
 # herds # animals  herd size 
farms with  (x 1000)  median (5% – 95%) 
finishing pigs 5688 6479  1139 (136 – 3844) 
piglets 2629 4517  1718 (211 – 4980) 
sows 2425 945  390 (77 – 1087) 
total 10742 11941    
 
The total number 10742 of herds with finishing pigs, piglets and sows is not the same as 
the total number of 7018 farms, because a farm can contain multiple herd types (e.g. 
sows and piglets). 
 
The yearly survey (Land- en tuinbouwcijfers, 2012) in 2011 reported 12,4 million animals 
in 6526 pig farms. However, these numbers are based on available stable spaces rather 
than transports, and they reflect the situation at April 1st rather than the yearly average. 
For these reasons the reported numbers in the yearly survey and Table 5 are not the 
same. 
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Figure 3 Map of commercial pig farm densities in The Netherlands (year 2011). The 
simulated epidemics start in De Peel (black circle), a densely populated 
livestock area.  
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2.d Simulations 
 
To compare different control strategies, 1000 artificial High Risk Periods (HRP) were 
generated, by choosing an index herd in De Peel (black circle in Fig. 2), doubling the 
kernel height (Fig. 1), and requiring that: 
- 5 farms are infected at the end of the HRP which lasts 5 weeks (default HRP), or 
- 10 farms are infected at the end of the HRP which lasts 6 weeks (extreme HRP)  
 
During the CSF epidemic in 1997/1998, it was estimated that 19 herds were infected at 
the moment the first case was detected (followed by a transmission boost before 
transport was officially prohibited, presumably infecting another 19 herds). This is 
generally considered an extreme HRP. With the increased hygiene, changes made in the 
production chain and decreasing farm numbers, we will choose 10 farms infected at the 
end of the HRP as the extreme scenario for the current situation. Half of this number – 5 
farms infected at the end of the HRP – is considered to be the default scenario. 
 
Upon detection of the first case, EU measures (strategy EU) will be applied: culling of 
infected premises (IP), transport regulations in protection (3 km around IP’s) and 
surveillance (10 km around IP’s) zones, as well as tracing and screening of dangerous 
contacts. When additional measures are applied, preemptive culling in 1 km around IP’s 
will be applied during the first 5 days. After this period, 1 km preemptive culling either 
continues (strategy cul_1km) or is replaced by emergency vaccination in 1 km, 2 km or 3 
km rings around IP’s. For vaccination either the E2-subunit vaccine (strategies 
vacE2_1km, vacE2_2km and vacE2_3km) or the C-strain vaccine (strategies vacC_1km, 
vacC_2km and vacC_3km) is used. 
 
The time between detection and culling of an IP is assumed to be one day. The time 
between culling of an IP and emergency vaccination or preemptive culling of herds in the 
control zone is also assumed to be one day. Culling and vaccination are assumed to be 
not limited by resources (i.e. vaccine doses, control teams, destruction capacity). 
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3. Results 
 
Each control strategy is applied to each of the 1000 default and 1000 extreme HRP’s. For 
each simulated epidemic the following characteristics are registered: 
- duration of epidemic (time between first and last detection) 
- number of detected farms 
- number of preemptively culled farms 
- number of vaccinated farms 
- number of not-detected herds (before final screening) 
- number of not-detected infected animals (before final screening) 
- number of truly positive herds found (during final screening) 
- number of not-detected herds (after final screening) 
- number of not-detected infected animals (after final screening) 
- number of tested herds (in 3 km protection zones) 
- number of tested animals (in 3 km protection zones) 
- number of initially false positive tested herds 
 
The final screening model is only applied to the default HRP’s. 
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3.a Effectiveness of control strategies for default HRP’s 
 
The effectiveness of the different control strategies is evaluated for the default HRP’s 
where 5 farms are infected at the end of the HRP which lasts 5 weeks (Tab. 6). 
 
The EU control strategy yields the longest and largest epidemics, although not nearly as 
long and large as the 1997/98 CSF epidemic in the Netherlands. Preemptive culling 
considerably shortens the epidemic but leads to a much larger number of depopulated 
farms. In the emergency vaccination strategies 8 (2-20) farms are preemptively culled 
during the first 5 days, after which farms are vaccinated in 1, 2, or 3 km rings around 
detected farms with the E2-subunit or C-strain vaccine. For both vaccines an increasing 
control circle decreases the epidemic duration and number of detected herds, with an 
accordingly increasing number of vaccinated herds. With identical control radius, the C-
strain vaccination strategies are more effective than the E2-subunit vaccination 
strategies, as was expected from the higher effectiveness of the C-strain vaccine at 
individual level. But surprisingly, the differences are not very large: C-strain vaccination 
leads to around 2 detected farms less and ends the epidemic around 12 days earlier. 
Emergency vaccination (with either vaccine) in 3 km rings around detected farms is more 
or less as effective as 1 km preemptive culling. 
 
The required depopulation capacity is highest for 1 km preemptive culling, at a median of 
5 farms or 10000 animals per week (see Appendix D for figures), in the early stages of 
the epidemic. In the vaccination strategies (regardless of the vaccine), the 1 km 
strategies require a median of 5 farms or 10000 animals per week to be vaccinated, the 
2 km strategies 10 farms of 30000 animals per week and the 3 km strategies 20 farms or 
50000 animals per week (Appendices D and E). However, in the most extreme cases 
(95th percentiles) these numbers increase with a factor 5. 
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Table 6 Effectiveness of control strategies for default HRP’s: epidemic duration, number of detected, preemptively culled and vaccinated 
farms and animals per epidemic; median values and (5% - 95%) interval between brackets. 
control 
strategy 
duration* (days) 
number of 
detected farms 
number of 
preemptively 
culled farms 
number of 
vaccinated farms 
number of culled 
animals 
(x1000) 
number of vaccinated 
animals 
(x1000) 
EU 202 (65 - 475) 40 (10 - 128) 0 (0 - 0) 0 (0 - 0) 115 (27 - 363) 0 (0 - 0) 
cul_1km 93 (35 - 199) 13 (5 - 27) 79 (26 - 173) 0 (0 - 0) 225 (72 - 488) 0 (0 - 0) 
vacE2_1km 136 (45 - 310) 19 (6 - 52) 8 (2 - 20) 98 (20 - 254) 79 (30 - 166) 213 (42 - 562) 
vacE2_2km 113 (37 - 236) 14 (5 - 32) 8 (2 - 20) 191 (56 - 414) 64 (25 - 123) 422 (114 - 884) 
vacE2_3km 104 (34 - 203) 12 (5 - 26) 8 (2 - 20) 278 (95 - 588) 58 (25 - 113) 599 (203 - 1241) 
vacC_1km 125 (42 - 264) 16 (5 - 41) 8 (2 - 20) 88 (19 - 223) 71 (28 - 145) 195 (42 - 483) 
vacC_2km 101 (36 - 208) 12 (5 - 27) 8 (2 - 20) 175 (51 - 379) 59 (25 - 110) 388 (103 - 802) 
vacC_3km 91 (31 - 185) 10 (4 - 22) 8 (2 - 20) 260 (83 - 515) 53 (22 - 100) 557 (174 - 1088) 
* Duration of the epidemic is defined as the time between the first and the last detection. 
 
 
 
 
 
Report C-strain vaccination against Classical Swine Fever  23  
 
3.b Effectiveness of control strategies for extreme HRP’s 
 
The effectiveness of the different control strategies is also evaluated in a more extreme 
starting situation where 10 farms are infected at the end of the HRP after 6 weeks (Tab. 
7). 
 
The more extreme starting situation leads to longer and larger epidemics than the default 
HRP starting situation (Tab. 6). The differences are however not large and the 95th 
percentiles are in fact comparable, showing that large epidemics are not only dependent 
on the starting situation, but can also develop during the control period due to 
stochasiticity. The comparison between the different control strategies is identical to the 
comparison made in the previous section for the default starting situations. So, the 
ranking of the strategies based on their effectiveness seems to be robust for the studied 
range. 
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Table 7 Effectiveness of control strategies for extreme HRP’s: epidemic duration, number of detected, preemptively culled and vaccinated 
farms and animals per epidemic; median values and (5% - 95%) interval between brackets. 
control 
strategy 
duration* (days) 
number of 
detected farms 
number of 
preemptively 
culled farms 
number of 
vaccinated farms 
number of culled 
animals 
(x1000) 
number of vaccinated 
animals 
(x1000) 
EU 226 (70 - 469) 51 (11 - 136) 0 (0 - 0) 0 (0 - 0) 143 (29 - 388) 0 (0 - 0) 
cul_1km 110 (51 - 202) 22 (10 - 42) 134 (65 - 248) 0 (0 - 0) 382 (181 - 693) 0 (0 - 0) 
vacE2_1km 160 (69 - 301) 34 (14 - 65) 11 (3 - 26) 165 (62 - 311) 128 (62 - 219) 362 (124 - 674) 
vacE2_2km 127 (63 - 244) 25 (12 - 45) 11 (3 - 26) 310 (130 - 546) 104 (53 - 175) 670 (277 - 1157) 
vacE2_3km 115 (56 - 212) 21 (11 - 36) 11 (3 - 26) 420 (208 - 735) 91 (50 - 146) 895 (451 - 1535) 
vacC_1km 150 (71 - 287) 31 (13 - 60) 11 (3 - 26) 156 (58 - 298) 119 (59 - 203) 342 (118 - 654) 
vacC_2km 120 (61 - 208) 22 (11 - 38) 11 (3 - 26) 284 (130 - 497) 93 (49 - 157) 616 (282 - 1061) 
vacC_3km 103 (54 - 188) 18 (9 - 30) 11 (3 - 26) 395 (198 - 678) 82 (43 - 134) 839 (422 - 1424) 
* Duration of the epidemic is defined as the time between the first and the last detection. 
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3.c Detection of infected herds during final screening 
 
During the (simulated) epidemics some infected herds may not be detected, because the 
number of infectious animals stays under the detection limit, either by vaccination or by 
chance. The final screening that takes place at least 30 days after the last detection or 
vaccination event, is designed to detect the infected animals in these herds. The results 
of the final screening (Tab. 8) are obtained by applying the final screening model to the 
simulated epidemics with default HRP’s (Tab. 6). 
 
Table 8 Final screening of infected herds per control strategy (default HRP’s): expected 
number of not-detected herds and animals before and after final screening and 
expected number of truly positive herds (cases) found during the final screening; 
median values and (5% - 95%) interval between brackets. 
control  
strategy 
number of not-detected herds 
per epidemic 
 
number of not-detected 
animals 
per epidemic 
before final 
screening 
after final 
screening 
declared as 
case during 
final scr. 
 
before final 
screening 
after final 
screening 
EU 1 (0 - 4) 1 (0 - 3) 0 (0 – 0.4)  1 (0 - 12) 1 (0 - 10) 
cul_1km 0 (0 - 1) 0 (0 - 1) 0 (0 - 0)  0 (0 - 2) 0 (0 - 2) 
vacE2_1km 3 (0 - 10) 2 (0 - 9) 0.2 (0 – 1.6)  26 (0 - 124) 18 (0 - 101) 
vacE2_2km 3 (0 - 10) 2 (0 - 9) 0.7 (0 – 2.3)  37 (0 - 129) 21 (0 - 106) 
vacE2_3km 3 (0 - 10) 2 (0 - 9) 0.7 (0 – 2.5)  38 (0 - 127) 21 (0 - 99) 
vacC_1km 3 (0 - 10) 3 (0 - 9) 0 (0 - 0)  19 (0 - 78) 19 (0 - 78) 
vacC_2km 4 (0 - 10) 4 (0 - 10) 0 (0 - 0)  24 (0 - 77) 24 (0 - 77) 
vacC_3km 4 (0 - 10) 4 (0 - 10) 0 (0 - 0)  28 (0 - 78) 28 (0 - 78) 
 
The control strategies differ in how many infected herds escape detection. The non-
vaccination strategies yield the least number of not-detected herds and animals. These 
numbers are greater for EU measures than for 1 km preemptive culling, because the 
epidemics under EU measures are much larger. Most not-detected not-vaccinated herds 
are sow herds with only one or a few infected animals. Because of this low 
seroprevalence, the sample sizes (designed to detect a seroprevalence of at least 5% in 
sow herds) are too small to detect these animals. Moreover, around 20% of the infected 
herds (for EU) are located outside the protection zone and not tested during the final 
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screening. For these reasons, the final screening has no (for cul1) or only limited (for EU) 
effect on the number of not-detected infected herds and animals after the final screening. 
 
Before the final screening, the vaccination strategies yield considerable numbers of not-
detected infected herds (0 to 10, with median of 3 or 4 herds), irrespective of the control 
radius or vaccine used. The C-strain vaccine may protect herds sooner, but when an 
infected herd is vaccinated, the C-strain vaccine will almost certainly prevent detection. 
The numbers of not-detected infected animals for the C-strain vaccination strategies are 
smaller than for the E2-subunit vaccination strategies, but they will not be detected 
during the final screening. This is because at the time of final screening, none of the 
infected C-strain vaccinated animals will be positive in the PCR test and there is no 
alternative test to distinguish them from not-infected C-strain vaccinated animals. 
 
For the E2-subunit vaccinated animals, the Erns ELISA does make a distinction between 
infected and non-infected animals. The large sample size taken on vaccinated farms 
(10% of all animals) compensates for the poor test sensitivity (of 73.4%, Tab. 3), 
leading to a reasonable chance of detection in the first ELISA stage. However, during the 
following confirmation stage with PCR, many herds – especially those infected early in 
the epidemic – will be tested negative by PCR and still escape detection. For this reason, 
the number of not-detected infected herds and animals is only moderately reduced by 
the final screening. 
 
All in all, the final screening in the E2-subunit vaccination strategies reduces the numbers 
of not-detected animals to levels comparable to the C-strain vaccination strategies. The 
numbers of not-detected herds in the E2-subunit vaccination strategies are even brought 
below the levels of the C-strain vaccination strategies by the final screening. 
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3.d Number of tested and false positive herds during final screening 
 
All farms in the protection zones of 3 km around detected herds, need to be tested 
during the final screening. Sample sizes are taken based on the type of herd and 
vaccination status. Most of the farms are not infected, but the test results can still point 
at a false positive result due to the non-perfect specificity of the ELISA’s (Tab. 3). 
 
The smallest number of herds and animals need to be tested in the 1 km preemptive 
culling strategy (Tab. 9), because of the small epidemics and small sample sizes in 
unvaccinated herds. The largest number of herds are tested for the EU control strategy 
because of the large epidemics affecting the largest geographical area. The number of 
animals to be tested though, is still moderate compared to the vaccination strategies. 
 
Obviously, the number of vaccinated herds to be tested increases with increasing control 
radius, while the number of not-vaccinated herds to be tested decreases. For the 3 km 
strategies the vaccination zones and protection zones coincide, so the non-vaccinated 
herds that are tested are all sow herds. The number of animals to be tested in vaccinated 
herds is much larger than in not-vaccinated herds, because one animal per pen is tested 
(10% of the total population). 
 
Finding a false positive in the non-vaccinated herds (using E2 serology) is very rare, 
because sample sizes are limited and the test specificity is high (99.999% at animal 
level). For C-strain vaccinated herds, false positive results do not occur because of the 
assumed 100% specificity of the PCR test. Considerable numbers of false positives are 
expected for the E2-subunit vaccinated herds that are tested by the Erns ELISA. The large 
sample sizes per herd combined with the non-perfect specificity (of 99.9% at animal 
level), diminish the probability of finding a tested herd truly negative. For instance, a 
not-infected E2-subunit vaccinated herd of 5000 finishers of which 500 are tested, has a 
1 – 0.999500 = 0.39 probability of being falsely identified as infected. The subsequent 
PCR testing will confirm the herd to be negative, but this involves a considerable amount 
of extra work (returning to herd, euthanizing the positive reactors, taking tonsil samples, 
testing samples in PCR). It is expected that 15% (13%–17%) of the E2-subunit 
vaccinated herds are initially declared false positive. 
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Table 9 Number of tested herds and animals in the final screening and expected number of initially false positive herds per control 
strategy; median values and (5% - 95%) interval between brackets. Non-vaccinated herds are tested by E2 serology, E2-subunit 
vaccinated herds by Erns serology (+ confirmation by PCR) and C-strain vaccinated herds by PCR. 
control  
strategy 
non-vaccinated  vaccinated 
number of tested 
herds 
number of 
tested animals 
(x1000) 
number of initially 
false positive herds 
 
number of tested 
herds 
number of tested 
animals (x1000) 
number of initially 
false positive herds 
EU 816 (312 - 1716) 31 (12 - 65) 0.3 (0.1 – 0.6)        
cul_1km 352 (135 - 665) 13 (5 - 25) 0.1 (0.1 – 0.3)        
vacE2_1km 445 (175 - 963) 18 (7 - 38) 0.2 (0.1 – 0.4)  116 (24 - 293) 20 (4 - 52) 17 (3 - 44) 
vacE2_2km 274 (113 - 526) 12 (5 - 23) 0.1 (0.0 – 0.2)  228 (67 - 485) 41 (11 - 85) 34 (10 - 72) 
vacE2_3km 128 (55 - 247) 7 (3 - 14) 0.1 (0.0 – 0.1)  336 (114 - 699) 59 (20 - 120) 50 (17 - 102) 
vacC_1km 429 (159 - 872) 17 (6 - 35) 0.2 (0.1 – 0.3)  104 (23 - 262) 19 (4 - 46) 0 (0 - 0) 
vacC_2km 260 (105 - 496) 11 (4 - 22) 0.1 (0.0 – 0.2)  212 (61 - 451) 37 (10 - 77) 0 (0 - 0) 
vacC_3km 122 (51 - 223) 7 (3 - 13) 0.1 (0.0 – 0.1)  315 (100 - 624) 55 (17 - 107) 0 (0 - 0) 
 
 
Report C-strain vaccination against Classical Swine Fever   29  
 
Discussion 
 
The results of this study show that for CSF epidemics starting in a densely populated 
livestock area (DPLA) such as De Peel, the minimal measures required by the EU are not 
sufficient to control the epidemic. As additional measure, both preemptive culling and 
emergency vaccination decrease the duration and size of the epidemic. Preemptive 
culling shortens the epidemic the most with the smallest control radius of 1 km, at the 
expense of the largest number of depopulated farms. Similar effectiveness is only 
achieved by emergency vaccination when the control radius is 3 km. In this respect, C-
strain vaccination is only slightly more effective than E2-subunit vaccination. 
 
The non-vaccination strategies lead to the least number of not-detected infected herds 
and animals after final screening. E2-subunit vaccination is expected to yield 
considerable numbers (median around 20) of not-detected animals after final screening 
that are comparable to C-strain vaccination after final screening, but the former are 
distributed over less herds. For E2-subunit vaccination strategies an additional one or 
two truly positive herds are detected during the final screening, while some dozens of 
herds are identified falsely positive. The final screening results show that for the non-
vaccination and C-strain vaccination strategies (almost) zero positive cases (true or 
false) are identified. 
 
The effectiveness and final screening of E2-subunit vaccination have been assessed in a 
previous evaluation (Bergevoet et al., 2007, Backer et al., 2009). However, the results 
cannot be compared directly because several improvements have been made and input 
has changed: (a) a more recent commercial pig database of 2011 is used, (b) variable 
farm sizes and mixed farms are taken into account, (c) the HRP starts in a DPLA and 
generates a fixed number of 5 or 10 infected herds, and (d) the detection is based on a 
detection limit of infectious animals rather than on a randomly drawn detection time. 
Four points are worth noting though.  
 
First, the 2011 pig farm database includes less farms than the previously used 2006 pig 
farm database. In the latter it was assumed that 1/3 of the farms contained a sow 
section, agreeing with a fraction of 35% now. The variable farm size in the current study 
does not have an effect on the detection times nor on the between-herd transmission in 
the model. 
 
Second, in the previous study it was found that the effectiveness of 1 km preemptive 
culling was comparable to the effectiveness of 2 km vaccination, whereas in this study it 
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is found to be comparable to the effectiveness of 3 km vaccination. This is presumably 
caused by the condition that epidemics now start in a DPLA. 
 
Third, a larger number of not-detected infected animals for non-vaccination strategies 
were predicted by the previous study. The new and more realistic method of detecting an 
infected farm at a certain number of infectious animals might be the cause of this. 
Regardless, the prediction of the previous study that the final screening brings the 
number of not-detected infected animals in vaccinated herds to the same level as not-
vaccinated herds, cannot be upheld in this study. 
 
Fourth, the final screening in the current study seems much less effective in detecting 
infected E2-subunit vaccinated herds. There are two reasons for this. First, the test 
sensitivity is now taken to be 73.4%, instead of 90% previously (based on the Bommeli 
(IDEXX) Erns ELISA). This will affect the probablity of finding an infected herd in the first 
stage of the final screening. But the second reason has a larger effect: in the previous 
study a follow-up sensitivity of 100% was assumed. It was argued that more testing in 
herds that were positive in the Erns ELISA would eventually eliminate all infected animals 
in that herd. In the current study, the confirmatory PCR testing is modelled in more 
detail, also taking the decreasing PCR sensitivity into account. 
 
The poor performance of the final screening in E2-subunit vaccinated herds can be 
improved by more intensive testing in positive herds. When pen mates are additionally 
tested to search for evidence of virus spread (and – when positive – subsequently tested 
by PCR), a 100% follow-up specificitiy can be approached. However, this also means that 
all false positive herds need to be tested under this more intensive protocol and that the 
expected number of truly positive herds (cases) found during the final screening will 
increase. The performance of the Erns screening could also be improved by starting the 
screening earlier during the epidemic, because it is more likely to find infected animals 
positive by PCR. The cases found in this way will not delay regaining the freedom-of-
infection status. Of course this provisional screening will not cancel the obligation to test 
the herds again in the actual final screening, but it is less likely to find truly positive 
cases then. 
 
Despite the faster immune response in animals that are C-strain vaccinated, the use of 
this vaccine is only slightly more effective in controlling the epidemic, compared to the 
E2-subunit vaccine. Apparently, the time scale of the E2-subunit vaccine induced immune 
response (approximately 10 days) is sufficiently small compared to the virus spread 
within a herd (4-5 weeks), to effectively halt the epidemic.  Moreover, the C-strain 
vaccine does not prevent the occurrence of not-detected infected herds and animals. It is 
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impossible to detect these because they cannot be distinguished from vaccinated 
animals.  
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Appendix A Effect of C-strain vaccine 
 
To be able to assess control strategies with C-strain vaccination, the model needed to 
include the effect of the C-strain vaccine on the animal-to-animal transmission of CSFV. 
Experimental results were available to parameterize the model, but they were mostly 
limited to vaccination-challenge experiments in the presence of sentinel (unvaccinated) 
contact animals. For this reason, the C-strain vaccine model is simpler than the E2-
subunit vaccine model that was developed previously (Bergevoet et al., 2007, Backer et 
al., 2009). 
 
The C-strain vaccine model is based on 9 vaccination-challenge experiments, reported by 
Kaden et al. (2001) and Graham et al. (2012). These experiments were carried out with 
short time intervals between vaccination: at 0 days post vaccination (dpv), 1 dpv, 3 dpv 
and 5 dpv, with various challenge virus strains. At longer time intervals all vaccinated 
animals were fully protected at the time of challenge (Dewulf et al., 2004). 
 
We will use the fraction of successful challenges as a measure of susceptibility (bearing in 
mind that the animals were inoculated, i.e. not naturally infected), and fitted an 
exponential decay function to the results (Fig. A1). The infectiousness of the vaccinated 
infected animals was assumed to be unaffected by the vaccine, because in each 
experiment (Kaden et al., 2001, Graham et al., 2012) with an infected vaccinated 
animal, all sentinel animals were contact infected. Furthermore, the period during which 
the vaccinated infected animals were PCR positive, was not shorter than for the 
unvaccinated control animals. For this reason, also the average infectious period of 
vaccinated infected animals was assumed to be unaffected by the vaccine. 
 
The effect of the C-strain vaccine on the animal-to-animal transmission parameters is 
compared to the effect of the E2-subunit vaccine in Fig. A2. Note that parameters such 
as infectiousness at large vaccination-infection intervals bear no meaning for the C-strain 
vaccine, as vaccinated animals are already fully protected against infection at that time. 
This is also clear when comparing the effective reproduction number (in a fully 
vaccinated population) for the two vaccines (Fig. A2.d) 
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Figure A1 Effect of C-strain vaccine on susceptibility as function of the infection 
moment; the model (solid line) is based on experimental results (open circles) 
of Kaden et al., 2001 (infection moments at 0 dpv), and Graham et al., 2012 
(infection moments >0 dpv); dpv: days post vaccination 
 
 
(a) 
 
(b) 
 
(c) 
 
(d) 
Figure A2 Effect of C-strain vaccine (solid line) and E2-subunit vaccine (dashed line) on 
(a) susceptibility, (b) infectiousness, (c) average infectious period and (d) 
effective reproduction number, as function of the infection moment (in dpv: 
days post vaccination)  
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Appendix B Test characteristics for final screening model 
 
Table B1 Test characteristics at animal level for commercial CSF serology tests, 
determined at Central Veterinary Institute 
test characteristics remarks 
 sens spec  
Prionics E2 ELISA 92% 98%  
IDEXX E2 ELISA 93% 99% used by CVI since 2006 
E2 VNT 94% 99.5% 
specificity after correction for 
crossreaction with BD and BVD 
Bommeli (IDEXX) Erns ELISA 89.1% 99.6% for finishing pigs 
Prionics Erns ELISA 73.4% 99.9% for finishing pigs 
 
E2-serology is used for unvaccinated animals. Samples are first tested with the Prionics 
E2 ELISA. When positive, they are tested in the IDEXX E2 ELISA. These tests combined 
have a sensitivity of 92% and a specificity of 99.98%. When samples are positive in both 
ELISA’s, they are tested in the E2 VNT (virus neutralisation test). For the standard CSF 
surveillance programme, around 50000 samples are tested yearly in this three-step 
procedure, yielding 0 positives. This gives a lower bound of the overall specificity of 1-
0.5/50000=0.99999 for an individual sample. The overall sensitivity is determined by the 
first ELISA that has the lowest sensitivity of 92%. Each of the ELISA’s takes one day, and 
the VNT takes another 5 days, yielding a total period of 7 days for the whole procedure 
to finish. 
 
Erns-serology is used for E2-subunit vaccinated animals. The test characteristics of the 
Erns ELISA’s have been determined in evaluation at the CVI. A panel of 226 E2-subunit 
vaccinated and inoculated (more than 28 dpv) animals served to determine the test 
sensitivities and a panel of 1847 field sera of finishing pigs served to determine the test 
specificities. Schroeder et al. (2012) report the results of a ring trial on a smaller panel 
(84 samples of E2-subunit vaccinated and challenged animals), in which the Bommeli 
(IDEXX) test correctly identified 85% and the Prionics test 56% of the samples. These 
percentages are not identical to the sensitivities (as the same samples are tested 
multiple times and test results are thus not independent), but they do show the same 
relation between the two tests as found in the in-house evaluation. As the Bommeli 
(IDEXX) test has been taken out of production, the individual test characteristics in the 
final screening model are taken to be the test characteristics of the Prionics Erns ELISA, 
i.e. 73.4%. Claims by the manufacturer that the sensitivity of this test has been 
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improved for E2-subunit vaccinated animals have not been validated yet in an 
appropriate panel. 
 
When the Erns ELISA is positive, tonsil samples are taken from the positively tested 
animals and tested by PCR, to determine whether the herd is declared positive or 
negative. The sensitivity of this PCR test decreases with time since infection, due to 
clearance of the virus. This means that even when a herd is tested truly positive in the 
ELISA, the PCR results can be negative, leading to a negatively declared herd. 
 
To determine how the ability of the PCR to detect infected animals depends on the time 
since infection, experimental data are used (Loeffen, 2008). In total 38 Paderborn-
infected animals (unvaccinated and E2-subunit vaccinated) that survived the acute phase 
were euthanized at various times since infection, and their tonsils PCR-tested. A logistic 
function was fitted through the results as sePCR(τ) = 1/(1+exp(0.088 τ – 7.4)) (Fig. B1). 
 
  
Figure B1 Sensitivity of PCR to detect infected animals as function of the time since 
infection; experimental data from Loeffen, 2008 (symbols near 1: positive 
PCR, symbols near 0: negative PCR), and fitted PCR sensitivity (solid line). 
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Appendix C Calculation of pig numbers per farm from pig transport data 
 
Dienst Regelingen (Ministry of Economic Affairs) provided pig transport data containing 
the number of pigs that were dispatched from each UBN (unique farm identifier) in 2011, 
in the categories: 
B: piglets 
V: finishers 
G1: sows and gilts 
G2: gilts of 7 months of age 
D: newly born piglets (ignored; these are dead piglets dispatched to Rendac) 
O: other finishers (ignored; these are presumably sows that are to be replaced) 
 
It is assumed that: 
- suckling piglets are maximally 4 weeks of age, 
- weaned piglets are maximally 9 weeks of age, 
- finishers are maximally 26 weeks of age and 
- gilts are maximally 35 weeks of age. 
 
Finishers will be in the the finisher category for 26 – 9 = 17 weeks and gilts will be in the 
the gilt category for 35 – 9 = 26 weeks. In calculating the number of animals from the 
pig transport data, no distinction is made between breeding and multiplier farms nor 
between finishing and growing farms. They differ in the type farms they are allowed to 
dispatch their animals to, but this does not affect the population calculation. For each 
farm type (simplifying) assumptions are made to calculate the number of sows, the 
number of finishers and gilts, and the number of piglets that are present in a farm at a 
specific time (Tab. C1). 
 
  
Report C-strain vaccination against Classical Swine Fever   38  
 
Table C1 Calculation of number of sows, finishers and piglets from pig transport data 
Farm type # sows 
# finishers  
+ # gilts 
# piglets 
Breeding farm (Fokbedrijf) 
- Sows have 27 piglets per year 
- No import of gilts or piglets  
(B+V+G1+G2) 
/27 
V 17/52 + 
(G1+G2) 26/52 
(B+V+G1+G2) 
9/52 
Finishing farm (Mestbedrijf) 
- Piglets enter at 9 weeks of age 
- No sows or piglets present 
0 
V 17/52 + 
(G1+G2) 26/52 
0 
Growing farm (Opfokbedrijf) 
- Piglets enter at 9 weeks of age 
- No sows or piglets present 
0 
V 17/52 + 
(G1+G2) 26/52 
0 
Weaned piglets farms (E/F bedrijven) 
- Piglets enter at 4 weeks of age 
- Dispatched at 9 or 26 weeks of age 
0 
V 17/52 + 
(G1+G2) 26/52 
(B+V+G1+G2) 
5/52 
Multiplier farm (Vermeerderaar) 
- Sows have 27 piglets per year 
- No import of gilts or piglets 
(B+V+G1+G2) 
/27 
V 17/52 + 
(G1+G2) 26/52 
(B+V+G1+G2) 
9/52 
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Appendix D Required depopulation and vaccination capacities 
 
 
 
Figure D1 Required depopulation capacity for EU measures and 1 km preemptive culling, 
in number of farms and animals per week: median value (solid line) and 5%-
95% interval (shaded area). 
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Figure D2 Required vaccination capacity for emergency vaccination with E2-subunit 
vaccine in 1 km, 2 km or 3 km around detected herds, in number of farms 
and animals per week: median value (solid line) and 5%-95% interval 
(shaded area). 
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Figure D3 Required vaccination capacity for emergency vaccination with C-strain vaccine 
in 1 km, 2 km or 3 km around detected herds, in number of farms and 
animals per week: median value (solid line) and 5%-95% interval (shaded 
area). 
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Appendix E Required vaccination capacities – table 
 
Table E1 Required number of farms and animals to be vaccinated using E2-subunit 
vaccination in 2 km (vacE2_2km) or 3 km (vacE2_3km) per week (week 1 is 
the first week of vaccination): median values and (5% - 95%) interval 
 vacE2_2km  vacE2_3km 
week number of farms number of animals 
(x1000) 
 number of farms number of animals 
(x1000) 
0 0 (0 - 0) 0 (0 - 0)  0 (0 - 0) 0 (0 - 0) 
1 0 (0 - 43) 0 (0 - 103)  0 (0 - 77) 0 (0 - 183) 
2 14 (0 - 59) 27 (0 - 141)  27 (0 - 108) 54 (0 - 244) 
3 15 (0 - 59) 33 (0 - 136)  26 (0 - 107) 54 (0 - 235) 
4 14 (0 - 58) 27 (0 - 127)  22 (0 - 98) 43 (0 - 206) 
5 10 (0 - 56) 18 (0 - 126)  8 (0 - 88) 16 (0 - 191) 
6 4 (0 - 52) 8 (0 - 120)  4 (0 - 79) 6 (0 - 176) 
7 5 (0 - 48) 8 (0 - 107)  1 (0 - 76) 1 (0 - 168) 
8 4 (0 - 49) 7 (0 - 109)  0 (0 - 68) 0 (0 - 150) 
9 2 (0 - 44) 2 (0 - 100)  0 (0 - 68) 0 (0 - 152) 
10 0 (0 - 40) 0 (0 - 91)  0 (0 - 64) 0 (0 - 135) 
11 0 (0 - 39) 0 (0 - 82)  0 (0 - 57) 0 (0 - 122) 
12 0 (0 - 35) 0 (0 - 81)  0 (0 - 55) 0 (0 - 114) 
13 0 (0 - 34) 0 (0 - 74)  0 (0 - 54) 0 (0 - 105) 
14 0 (0 - 30) 0 (0 - 65)  0 (0 - 47) 0 (0 - 100) 
15 0 (0 - 29) 0 (0 - 63)  0 (0 - 42) 0 (0 - 91) 
16 0 (0 - 26) 0 (0 - 54)  0 (0 - 33) 0 (0 - 68) 
17 0 (0 - 24) 0 (0 - 55)  0 (0 - 28) 0 (0 - 64) 
18 0 (0 - 23) 0 (0 - 46)  0 (0 - 30) 0 (0 - 62) 
19 0 (0 - 22) 0 (0 - 48)  0 (0 - 25) 0 (0 - 48) 
20 0 (0 - 18) 0 (0 - 38)  0 (0 - 23) 0 (0 - 41) 
21 0 (0 - 17) 0 (0 - 36)  0 (0 - 19) 0 (0 - 36) 
22 0 (0 - 13) 0 (0 - 26)  0 (0 - 10) 0 (0 - 20) 
23 0 (0 - 13) 0 (0 - 26)  0 (0 - 0) 0 (0 - 0) 
24 0 (0 - 12) 0 (0 - 19)  0 (0 - 0) 0 (0 - 0) 
25 0 (0 - 4) 0 (0 - 9)  0 (0 - 0) 0 (0 - 0) 
26 0 (0 - 5) 0 (0 - 8)  0 (0 - 0) 0 (0 - 0) 
27 0 (0 - 7) 0 (0 - 13)  0 (0 - 0) 0 (0 - 0) 
28 0 (0 - 0) 0 (0 - 0)  0 (0 - 0) 0 (0 - 0) 
Two remarks: 
- For the first week of vaccination (week 1) the model predicts not too many farms 
to be vaccinated (median value of 0); however in practice detections will occur in 
this early stage of the epidemic due to the enhanced screening and tracing. This is 
not explicitly included in the model. 
- Culling and vaccination capacities are not taken into account in the model; this 
will play a larger role for 3 km vaccination than for 2 km vaccination. For this 
reason the difference in epidemic duration and size for 2 and 3 km vaccination will 
in practice be smaller than predicted by the model. As a consequence, the 
difference between the required vaccination capacity between the two strategies 
will be larger 
